Holiday notice

FDA Approves Jynneos FDA Approves Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults

FDA Approves Jynneos FDA Approves Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults COPENHAGEN, Denmark, September 24, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today an

FDA Alerts Health Care Professionals and Patients to Voluntary Recall of Ranitidine Medicines

FDA Alerts Health Care Professionals and Patients to Voluntary Recall of Ranitidine Medicines September 27, 2019 -- The U.S. Food and Drug Administration is alerting health care professionals and patients to a voluntary recall of over-the-counter (OTC) r

AHA News: Adopted Babys Unexpected Heart Problem Brought Unexpected Joy

AHA News: Adopted Babys Unexpected Heart Problem Brought Unexpected Joy FRIDAY, Sept. 20, 2019 (American Heart Association News) -- When their hopes of adopting a child from China were stretched thin by years of wait, Vanessa and Chris Zoog asked for a b

FDA Approves Rybelsus FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes

FDA Approves Rybelsus FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes PLAINSBORO, N.J., Sept. 20, 2019 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (

Drug Safety Communication: Imodium (loperamide) for Over-the-Counter Use - FDA Limits Packaging To Encourage Safe Use

Drug Safety Communication: Imodium (loperamide) for Over-the-Counter Use - FDA Limits Packaging To Encourage Safe Use Audience: Consumer, Pharmacy, Family Practice [9-20-2019] UPDATE To help address loperamide abuse and misuse, FDA approved changes t